📢 We’re proud to see VitrofluidiX mentioned in Preqin First Close Weekly (January 23, 2026).
In this edition, Preqin highlights “new ventures on the path to phase out animal testing,” underlining the growing global momentum to reduce reliance on animal models and accelerate the adoption of advanced, human-relevant technologies. 🧬🔬
This shift is driven not only by scientific and ethical considerations, but also increasingly by private capital recognizing the long-term value and scalability of innovative in vitro solutions.
At VitrofluidiX, we are excited to be part of this transformation and to contribute to building the next generation of research platforms. 🚀
A big thank you to Preqin for featuring this important topic!